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ABSTRACT
Fox-1 is a regulator of tissue-specific splicing, via
binding to the element (U)GCAUG in mRNA pre-
cursors, in muscles and neuronal cells. Fox-1 can
regulate splicing positively or negatively, most likely
depending on where it binds relative to the regu-
lated exon. In cases where the (U)GCAUG element
lies in an intron upstream of the alternative exon,
Fox-1 protein functions as a splicing repressor to
induce exon skipping. Here we report the mecha-
nism of exon skipping regulated by Fox-1, using the
hF1c gene as a model system. We found that Fox-1
induces exon 9 skipping by repressing splicing of
the downstream intron 9 via binding to the GCAUG
repressor elements located in the upstream intron 8.
In vitro splicing analyses showed that Fox-1 pre-
vents formation of the pre-spliceosomal early (E)
complex on intron 9. In addition, we located a region
of the Fox-1 protein that is required for inducing
exon skipping. Taken together, our data show a
novel mechanism of how RNA-binding proteins
regulate alternative splicing.
INTRODUCTION
Alternative pre-mRNA splicing is one of the central
mechanisms for the regulation of gene expression in
eukaryotic cells. It allows the generation of functionally
distinct proteins from a single gene. It has been estimated
that 40–60% of human genes are alternatively spliced.
Moreover, alternative splicing is often regulated in a
cell-type, tissue or developmentally speciﬁc manner [for
reviews, see (1–3)].
The splicing reaction is carried out by the spliceosome, a
large ribonucleoprotein complex containing ﬁve small
nuclear ribonucleoproteins (snRNPs) and many protein
splicing factors. Spliceosome assembly occurs in an
ordered manner within each intron. The initial step for
spliceosome formation is assembly of early (E) complex
(4,5): U1 snRNP interacts with the 50 splice site, SF1
(splicing factor 1) binds to the branch point, and the
U2AF65/35 heterodimer binds to the pyrimidine tract and
the 30 splice site. In an ATP requiring step, U2 snRNP
tightly associates with the branch site, generating the
A complex. Subsequently, the U4/U6/U5 tri-snRNPs
associate to the A complex to form the B complex. After
RNA–RNA rearrangements occur, the catalytically acti-
vated spliceosome is formed. During these rearrange-
ments, the U1 and U4 snRNPs dissociate and the U6
snRNA contacts with the 50 splice site and U2 snRNA.
This is the catalytic C complex spliceosome in which the
two trans-esteriﬁcation reactions of splicing occur, result-
ing in exon ligation and lariat intron release (6–8).
Spliceosome assembly is regulated by several non-
spliceosomal RNA-binding proteins, such as SR and
hnRNP proteins. SR proteins usually play key roles in
constitutive and alternative splicing, by mediating splicing
activation via binding to exonic splicing enhancers (ESEs).
In contrast, hnRNP proteins act as splicing repressors via
binding to exonic splicing silencers (ESSs) and intronic
splicing silencers (ISSs) (9). These proteins are extensively
studied for their eﬀect to spliceosome assembly in
alternative splicing, and are thought to aﬀect the initial
step of spliceosome assembly, the E complex formation.
Recently, several tissue-speciﬁc splicing regulators have
been reported. For example, a neuron-speciﬁc RNA-
binding protein, Nova-1, binds to the RNA sequence
UCAUY and regulates the alternative splicing of several
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(CUG-BP and ETR3-like factors) family proteins are
implicated in regulation of tissue-speciﬁc splicing of
several genes, including cTNT, IR and a-actinin (12–14).
In our previous study, we identiﬁed vertebrate homo-
logs of the Caenorhabditis elegans Fox-1 protein in
zebraﬁsh and mouse. Fox-1 is an RNA-binding protein
that contains an RNA recognition motif (RRM). In
mouse, Fox-1 is expressed in brain, heart and skeletal
muscle. Our SELEX experiments showed that zebraﬁsh
Fox-1 protein binds speciﬁcally to the pentanucleotide
GCAUG (15). Interestingly, it has been reported that
(U)GCAUG is essential for the alternative splicing of
several genes (3). Furthermore, a recent computational
analysis revealed that the UGCAUG element is over-
represented in the downstream introns of neuron-speciﬁc
exons and is conserved among vertebrate species (16).
Fox-1 induces muscle-speciﬁc exon skipping through
binding to the GCAUG repressor element upstream
of alternative exon in the human mitochondrial ATP
synthase g subunit (hF1g) gene (15). In the case of
calcitonin/CGRP, two copies of UGCAUG in the
upstream intron and the regulated exon are essential for
the induction of exon skipping by Fox-1 or its paralog
Fox-2 (17). In contrast, exon inclusion in ﬁbronectin,
non-muscle myosin heavy chain (NMHC)-B, c-src
and FGFR2, 4.1R is induced by Fox proteins via the
(U)GCAUG enhancer element in the downstream intron
(15,18–21). Thus, in the known cases so far, the
(U)GCAUG element that resides in the intron upstream
of alternative exon functions as a repressor element,
whereas the element that activates exon inclusion is found
in the intron downstream of the alternative exon. Thus, it
is likely that Fox proteins function as both splicing
repressor and activator, depending on where they bind
relative to the aﬀected exon. However, little is known
about the molecular mechanisms of how Fox proteins
regulate such alternative splicing.
To examine the molecular mechanism of exon skipping
by Fox-1, we studied its eﬀect on the spliceosome assembly
using the hF1g gene as a model. Here we report that Fox-1
induces exon 9 skipping by repressing splicing of the
downstream intron 9 via binding to the GCAUG repressor
element in intron 8. The splicing eﬃciency of intron 8 was
not aﬀected much by Fox-1 protein. In vitro splicing
analyses show that Fox-1, by binding to the GCAUG
element in intron 8, prevents formation of the pre-
spliceosomal E complex onto intron 9. Such repression
by Fox-1 represents a novel mechanism for splicing
regulation by tissue-speciﬁc splicing regulators. In addi-
tion, we identiﬁed a region of the Fox-1 protein that is
required for inducing the exon skipping, suggesting that
this region plays a key role in interacting with other
splicing factor(s) to regulate alternative splicing.
MATERIALS AND METHODS
Plasmids
The pCS2+MT mouse Fox-1/A2BP (NM_021477) was
described previously (15). The coding sequence of mouse
Fox-1/A2BP was cloned into pCS2 vector containing Flag
peptide (MDYKDDDDK). The pCS2+MT F-A mutant
was constructed using chimeric PCR ampliﬁcation, muta-
tion was induced into the RNP motif of Fox-1 (AAGGG
ATTTGGTTTCGTAACTTTC to AAGGGATTTGGT
GCTGTAACTTTC). For F-A mutant, we used Fox-1-S,
F-A-1, F-A-2, Fox-1-AS primers.
Fox-1-S: CCCAAGCTTATGAATTGTGAAAGAGA
GCA
F-A1: TTTGGTGCTGTAACTTTCGAAAATAGT
F-A2: GAAAGTTACAGCACCAAATCCCTTGGA
Fox-1-AS: TTTGATATCTTAGTATGGAGCAAAA
CGG
To construct deletion mutants of mFox-1 (N, C1,
C2, C3, C4), the mFox-1 cDNA fragments corre-
sponding to nucleotides 348–1191 (N), 1–885 (C1),
1–921 (C2), 1–978 (C3) and 1–1014 (C4) in the
coding sequence were ampliﬁed by PCR and cloned into
pCS2+MT-derived plasmid that contained the sequence
for SV40 NLS (PKKKRKVKL). To construct deletion
mutants of mouse Fox-1, the following primers were used.
N-S:TTTGATATCTTATGTCATCACGCGTGCTG
N-AS: TTTGATATCTTAGTATGGAGCAAAA
CGG
Fox-1-S: CCCAAGCTTATGAATTGTGAAAGAGA
GCA
C1-AS: GCAGATATCTTAGCCATAGGCCGGG
ATT
C2-AS: GCTCTAGATTAGTCTGCACCATAAAA
TCC
C3-AS: GCTCTAGATTAAGCGGCAGTGGCAG
GGGT
C4-AS: GCAGATATCTTAGGCAGCATAAACT
CGT
The hF1gL, hF1gS and hF1gSmt mini-genes were
described previously (15). To construct the hF1g 50SSmt
and hF1gBPmt mini-genes, base-substitution were intro-
duced into the 50 splice site in intron 9 (gtaaagttca to
caaaacatca) and the branch point in intron 8 (tcttgac to
tcgcgug), respectively, by chimeric PCR ampliﬁcation.
To construct the Ex8-9 and Ex9-10 mini-genes, we used
hF1gS mini-gene as a template for PCR ampliﬁcation, and
the ampliﬁed fragments were cloned into pCMV sport
vector (Life Technologies). The Ex8-9 mt and Ex9-10 mt
mini-genes were constructed in the same manner using
hF1gSmt mini-gene.
Transfection experiments
CV-1 cells were maintained in DMEM supplemented with
10% FBS. Transfection was performed by the calcium
phosphate DNA precipitation method as described pre-
viously (13). The myc fusion proteins expressed in
transfected cells were examined by western blotting
using anti-myc anti-body (cMyc 9E10; Santa Cruze
Biotechnology). As a loading control of western blotting,
U2AF65 was detected by anti-U2AF65 antibody (Sigma).
To analyze splicing products from hF1g mini-gene by
RT-PCR, the following F1-2903 and F1-2389 oligonu-
cleotides were used. For hF1gS, hF1gSmt,
hF1gmt+3GCAUG, hF1g 50SSmt, hF1g branch mt,
5304 Nucleic Acids Research, 2007, Vol. 35, No. 16Ex8-9 and Ex8-9 mt mini-genes, F1-2903 and T7 primer
were used. For Ex9-10 and Ex9-10 mt mini-genes, Ex9-10S
and T7 primers were used.
F1-2903: GTCATCACAAAAGAGTTGATTG
F1-2389: CACTGCATTCTAGTTGTGGTTTGT
Ex9-10S: CGGGATCCATTAATGAAAATCAAGT
TCC
PCR products were electrophoresed in 5% native
polyacrylamide gels, and visualized by phosphorimager.
Splicing products were quantiﬁed using NIH Image J
software.
In vitro splicing andspliceosomal assembly
Human embryonic kidney cells (HEK293) were grown in
DMEM containing 10% FBS. For preparation of nuclear
extracts, HEK293 cells grown in 150mm dishes were
transfected with 12mg plasmids/dish using TransIT-293
Transfection Reagent (Mirus). Nuclear extracts were
prepared from HEK293 cells transfected with pCS2
expression plasmids encoding Flag peptide or Flag-
tagged mouse Fox-1 protein according to the small-scale
nuclear extraction procedure (22).
Expression of Flag mFox-1 was conﬁrmed by western
blotting using anti-Flag tag antibody M2 (Sigma). Pre-
mRNAs (2.5 10
4c.p.m.) were incubated in 5mlo f
reaction mixture containing 1.6 mM MgCl2, 0.5 mM
ATP, 20 mM creatine phosphate and 3ml of nuclear
extracts (1.5ml HeLa nuclear extract and 1.5ml transfec-
tant HEK293 nuclear extract). After incubation, the
reaction was terminated by treatment with proteinase K
at 378C for 20min. The splicing products were extracted
and separated by electrophoresis on 6% polyacrylamide
gels containing 8M urea and autoradiographed with
X-ray ﬁlm (RX-U, Fuji Photo Film Co.). To analyze
spliceosome assembly, pre-mRNAs were incubated under
the splicing condition and treated with heparin, and the
spliceosomal complex was separated on 4% native
polyacrylamide gels. For the E complex assembly analysis,
pre-mRNAs were incubated in ATP-depleted nuclear
extract without heparin treatment, and the spliceosomal
complexes were separated by 1.5% native agarose gel (4).
RESULTS
Fox-1 induces muscle-specific exonskipping of hF1c
pre-mRNA viabinding to GCAUG repressor elements
In the previous study, we showed that zebraﬁsh Fox-1
protein regulates tissue-speciﬁc splicing of several genes
via the GCAUG elements, using a heterogeneous system
in which zebraﬁsh Fox-1 was expressed in mammalian
cells (15). In this study, we focused on mouse Fox-1 in
order to reveal molecular mechanism of tissue-speciﬁc
splicing in mammalian cells. As a ﬁrst step, we attempted
to reconﬁrm whether mouse Fox-1 induces tissue-speciﬁc
splicing via binding to GCAUG elements using hF1g
gene, as is the case of zebraﬁsh Fox-1. Exon 9 of the hF1g
gene is excluded from the splicing products in a muscle-
speciﬁc manner (23,24) and four copies of GCAUG
element reside in intron 8 (Figure 1A). We co-transfected
the hF1g mini-gene constructs with mFox-1 expression
plasmids into CV-1 cells, and analyzed RNA products
of hF1g gene by RT-PCR. When hF1gL plasmids were
transfected, exclusion and inclusion of exon 9 occur
almost equally. In contrast, overexpression of Fox-1
proteins promoted exon 9 exclusion (Figure 1B, lanes 1
and 2). The F-A mutant, in which an amino acid mutation
was introduced in RNP1 of mFox-1, was not able to bind
to RNA in vitro (data not shown). Fox-1 F-A mutant
protein could not induce exon 9 skipping of hF1g gene
(Figure 1B, lane 3), although the protein was properly
expressed and localized to nucleus (Figure 1C and data
not shown). These results indicated that Fox-1 promotes
exon 9 skipping of hF1g in a manner depending on its
RNA-binding activity.
Next we performed a transfection assay using various
hF1g derivative mini-genes (Figure 1A). The hF1gS mini-
gene, that lacks a large portion of intron 8 and hence
contains only a single copy of GCAUG, was transfected
with mFox-1 expression plasmids. We found that exon
9 skipping was induced by Fox-1 (Figure 1B, lanes 4–6).
In contrast, when the hF1gSmt mini-gene in which base
substitutions were introduced into the GCAUG sequence
of hF1gS was transfected, exon 9 skipping was not largely
induced by Fox-1 (Figure 1B, lanes 7–9). Insertion of three
copies of GCAUG to the hF1gSmt mini-gene strongly
restored induction of exon 9 skipping by Fox-1 protein
(Figure 1B, lanes 10–12). Taken together, we concluded
that mouse Fox-1 induces exon 9 skipping via binding to
the GCAUG element. In these experiments, however, we
found that splicing eﬃciency between the mini-genes was
somehow diﬀerent. It may be due to RNA context such as
a secondary structure. Alternatively, it is possible that the
sequence changes in these mini-genes may aﬀect some
positive elements present in the wild-type construct.
Fox-1induces exon 9skippingof hF1cby repressing the
splicingofintron9viabindingtoGCAUGelementinintron8
Fox-1 induces exon 9 skipping of hF1g via binding to
GCAUG, but its mechanism of action is unclear. As a ﬁrst
step to understand this, we examined whether the Fox-1
protein regulates the splicing of intron 8, intron 9 or
both introns. Two mini-genes, Exon 8-9 and Exon 9-10,
containing either intron 8 or 9, respectively, were
constructed. The Exon 9-10 mini-gene contains a portion
of the preceding intron 8 with the GCAUG element, in
addition to exons 9 and 10 and the intervening intron 9.
The branch site in intron 8 was disrupted by base
substitution mutations (Figure 2A and B). Since the
GCAUG repressor element is located in intron 8, we
expected that Fox-1 only would repress the splicing
reaction of intron 8. However, transfection experiments
showed that when Exon 8-9 pre-mRNA was expressed in
CV1 cells, the splicing reaction of intron 8 was not aﬀected
much by Fox-1 (Figure 2A, lanes 1–3). In contrast,
surprisingly, splicing of Exon 9–10 pre-mRNA was
strongly repressed by Fox-1 (Figure 2B, lanes 1 and 2).
Fox-1 F-A mutant protein could not repress intron 9
splicing (Figure 2B, lane 3). Mutations to the GCAUG
element in the Exon 9-10 mini-gene reduced repression of
intron 9 splicing (Figure 2B, lanes 4 and 5). These results
Nucleic Acids Research, 2007, Vol. 35, No. 16 5305indicated that Fox-1 represses splicing of intron 9, without
aﬀecting intron 8 splicing, via the GCAUG element
located in intron 8.
Next, we examined whether exon 9 skipping is induced
by the repression of intron 9 splicing. We constructed two
mutants of hF1g mini-gene to disrupt splicing of either
the upstream or downstream intron without aﬀecting
exon skipping. BPmt contains the branch point mutation
upstream of exon 9 to disrupt intron 8 splicing, while
the 50 splice site of intron 9 was mutated in 50SSmt
(Figure 2C). When the BPmt mini-gene alone was
transfected into CV-1 cells, we detected three kinds of
RNA products, corresponding to the unspliced pre-
mRNA, intron 9-spliced form and exon 9-skipping form,
as expected. When functional Fox-1 protein was co-
expressed, the splicing of intron 9 was repressed and exon
9 skipping was induced concomitantly (Figure 2C, lanes
1–3). In the case of 50SSmt, we detected only unspliced
pre-mRNA and exon 9-skipping products, irrespective of
the presence of Fox-1 protein (Figure 2C, lanes 4–6).
Taken together, we conclude that Fox-1 induces exon 9
skipping in hF1g by repression of intron 9 splicing.
Fox-1 represses the splicing ofintron 9viathe GCAUG
element in intron 8 invitro
To investigate the possible molecular mechanism of
repression of intron 9 splicing by Fox-1, we employed an
in vitro splicing system using two kinds of reporter
transcripts. Ex9-10+3GCAUG contains three copies of
GCAUG, whereas Ex9-10GCAUG does not have any
GCAUG element.Nuclearextractswereprepared fromthe
HEK293 cells expressing Flag-tagged mouse Fox-1 protein
or Flag peptide alone, and mixed with HeLa nuclear
extracts for in vitro splicing. Expression of Flag-tagged
Fox-1 was conﬁrmed by western blots using a-Flag tag
antibody (Figure 3A). Both the Ex9-10+3GCAUG and
the Ex9-10GCAUG transcripts were incubated in mock
or Fox-1-overexpressed nuclear extracts. In vitro splicing
showed that Fox-1 repressed the splicing of intron 9 in
Ex9-10+3GCAUG transcripts (Figure 3B, lanes 1–5).
In contrast, the intron 9 splicing of Ex9-10GCAUG was
not repressed by Fox-1 (Figure 3B, lanes 6–10). These
results led us to conclude that the splicing regulation
by Fox-1 is faithfully recapitulated by our in vitro system.
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Figure 1. Mouse Fox-1 induces exon 9 skipping of hF1g pre-mRNA via binding to GCAUG element. (A) The schematic representation of various
hF1g mini-genes. The Fox-1-binding sequence GCAUG and its mutated sequence CGAUG are shown as open and closed circles, respectively.
(B) Transfection assays of various hF1g mini-genes into CV-1 cells. The hF1gL (lanes 1–3), hF1gS (lanes 4–6), hF1gSmt (lanes 7–9) and
hF1gSmt+3GCAUG mini-genes (lanes 10–12) were co-expressed with pCS2+MT vector (lanes 1, 4, 7, 10), Fox-1 (lanes 2, 5, 8, 11) and F-A mutant
(lanes 3, 6, 9, 12). Splicing products were analyzed by RT-PCR. Splicing products are schematically shown on the right. All experiments were
performed more than three times. Average percentage and SD of exon 9 exclusion are shown at the bottom of each lane. (C) Upper panel shows
western blotting of cell extracts to detect Fox-1 proteins: Mock, Fox-1 and Fox-1 F-A, expressed from the pCS2+MT vector using the anti-Myc
antibody. The positions of molecular size markers are shown on the right. Lower panel shows western blotting of the same cell extracts with
anti-U2AF antibody as a loading control.
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complex on intron9via bindingto intron 8
To identify the step at which the splicing reaction of intron
9 is blocked by Fox-1, we analyzed spliceosome assembly
on the Ex 9-10+3GCAUG and Ex9-10"GCAUG pre-
mRNAs in vitro. Fractionation of splicing reactions
by non-denaturing gel electrophoresis can be used to
show a well-deﬁned pattern of shifts corresponding to
sequential complexes along the assembly pathway. For the
Ex8-9 8 9
hF1gS 8 9 10
Ex8-9mt 8 9
9 10
9 10
Ex9-10
Ex9-10mt
M
o
c
k
F
o
x
-
1
F
-
A
M
o
c
k
F
o
x
-
1
F
-
A
M
o
c
k
F
o
x
-
1
F
-
A
M
o
c
k
F
o
x
-
1
F
-
A
GFP
GFP
16.3
±1.9
12.0
±2.1
16.3
±2.0
20.2
±1.7
17.5
±0.3
19.7
±1.7
123456
spliced (%)
lane
33.7
±5.3
11.8
±5.7
31.1
±4.2
30.4
±3.7
32.9
±2.1
36.0
±2.0
123456
spliced (%)
lane
hF1gSmt
+3GCAUG 8 9 10
Intron 8 Intron 9
Intron 8
Intron 9
Intron 8 Intron 9
BP mt 8 9 10
5′SS mt 8 9 10
M
o
c
k
F
o
x
-
1
F
-
A
M
o
c
k
F
o
x
-
1
F
-
A
1 2 3 4 5 6 lane
Ex8-9 Ex8-9mt
Ex9-10 Ex9-10mt
BP mt 5′SS mt
A
B
C
GCAUG
CGAUG
ucuugac AGguaaagu
cugcgug
BP
BPmt
5′SS
GCcauuuca 5′SSmt
↑ ↑ ↑ ↑
Figure 2. Mouse Fox-1 induces exon 9 skipping of hF1g pre-mRNA by repressing the splicing of intron 9 via binding to GCAUG element in
intron 8. (A) Analysis of intron 8 splicing in CV-1 cells. The Ex8-9 (lanes 1–3) and Ex8-9 mt mini-genes (lanes 4–6) were co-transfected with
pCS2+MT vector (lanes 1 and 4), mFox-1 (lanes 2 and 5), F-A (lanes 3 and 6). The splicing products were analyzed by RT-PCR. A GFP plasmid
was cotransfected as an internal reference for transfection eﬃciency, RNA recovery and loading. The positions of spliced products and GFP are
indicated on the right. Average percentage and SD of splicing eﬃciency are shown at the bottom of each lane. (B) Analysis of intron 9 splicing in
CV-1 cells. Transfection analyses of the Ex9-10 (lanes 1–3) and Ex9-10 mt mini-genes (lanes 4–6) with pCS2+MT vector (lanes 1 and 4), mFox-1
(lanes 2 and 5), F-A (lanes 3 and 6). The positions of spliced products and GFP are indicated on the right. Average percentage and SD of splicing
eﬃciency are shown at the bottom of each lane. (C) Transfection analyses of the BPmt (lanes 1–3) and 50SSmt (lanes 4–6) mini-genes with
pCS2+MT vector (lanes 1 and 4), mFox-1 (lanes 2 and 5), F-A (lanes 3 and 6). Schematic representation of mini-genes is shown on the left of each
panel. Open and closed circles show the GCAUG element and its mutated element, CGAUG, respectively. Open and closed triangles show branch
point (BP) and its mutated site, respectively. A cross represents a mutated 50 splice site in intron 9. Sequences of these elements are shown at the
bottom. A bold letter represents the branch point nucleotide.
Nucleic Acids Research, 2007, Vol. 35, No. 16 5307spliceosome assembly analysis, Ex9-10+3GCAUG or
Ex9-10GCAUG transcripts were incubated in Mock
extract or Fox-1 extracts in the presence of ATP, and
separated on native polyacrylamide gels. We found that
spliceosome assembly on Ex9-10+3GCAUG transcripts
occurred in the mock nuclear extract, although splicing
complexes A, B and C could not be well separated in the
gel (Figure 4A, lanes 1 and 2). In contrast, H/E complex
seemed to be accumulated in Fox-1 nuclear extracts
(Figure 4A, lanes 3 and 4). These complexes migrated
more slowly in the presence of Fox-1. It may suggest that
Fox-1 associated with the complexes through binding
to Ex9-10+3GCAUG pre-mRNA. The H/E complex
accumulation was not detected on Ex9-10GCAUG
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Figure 4. Fox-1 blocks formation of the pre-spliceosomal early
(E) complex on intron 9 via binding to GCAUG element in intron 8.
(A) Spliceosomal complex formation on the Ex9-10+3GCAUG (lanes
1–4) and the Ex9-10 GCAUG (lanes 1, 2, 5 and 6) transcripts in
Mock nuclear extracts (lanes 1 and 2) or nuclear extracts containing
Flag-tagged mFox-1 (lanes 3, 4, 7 and 8) under normal splicing
condition in the presence of ATP for the indicated time above each
lane. Spliceosomal complexes were separated by 4% native polyacry-
lamide gels and position of each complex is indicated on the left.
(B) Spliceosomal complex formation on the hF1gEx 9-10 transcripts in
the absence of ATP. Transcripts of the Ex9-10+3GCAUG (lanes 1–4)
and the Ex9-10 GCAUG (lanes 5–8) were incubated in Mock nuclear
extracts (lanes 1, 2, 5 and 6) or Fox-1 nuclear extracts (lanes 3, 4, 7 and
8) in the absence of ATP and separated on a 1.5% native agarose gel.
Positions of pre-spliceosomal complexes E and H are indicated on
the left.
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Figure 3. Fox-1 represses the intron 9 splicing in vitro.( A) Western
blotting of the nuclear extracts using anti-Flag and anti-U2AF
antibodies. HeLa cell nuclear extracts were mixed with nuclear extracts
of HEK293 cells transfected with pCS2-Flag vector alone (Mock) or
pCS2 Flag-mFox-1 (Flag Fox-1). The positions of molecular size
markers are shown on the right side of upper panel. In addition to the
band at the expected size, an additional band was detected (asterisk).
(B) In vitro splicing reaction of Ex9-10+3GCAUG (lanes 1–4) and
Ex9-10GCAUG (lanes 5–8) in Mock nuclear extracts (lanes 2, 3, 7
and 8) or nuclear extracts containing Flag-tagged mFox-1 (lanes 4, 5, 9
and 10) for indicated time above each lane. Pre-mRNAs and splicing
products are indicated schematically on the right.
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the H complex from the E complex, we next resolved the
spliceosome E complex using a native agarose gel in the
absence of ATP. The formation of E complex is ATP-
independent and occurs at 308C. Moreover, detection of E
complex formation requires separation conditions lacking
heparin treatment (4). Under these conditions, a complex
was eﬃciently assembled on the Ex9-10+3GCAUG
transcripts in mock extracts. This complex disappeared
by addition of heparin, indicating that it is E complex
(data not shown). In contrast, E complex assembly was
not detected in Fox-1 extract (Figure 4B, lanes 1–4). In the
case of the Ex9-10GCAUG transcript, E complex
formation occurs eﬃciently in both mock and Fox-1
extracts (Figure 4B, lanes 5–8). These results indicated
that Fox-1, by binding to GCAUG element in intron 8,
represses intron 9 splicing by blocking formation of the
pre-spliceosomal E complex on intron 9.
Identification ofthe functionaldomain of Fox-1required
forinduction ofexon skipping
To identify the Fox-1 protein domain required for
induction of exon skipping, we created a series of deletion
mutants that contain NLS to ensure proper nuclear
localization (Figure 5A). We conﬁrmed expression of
these mutant proteins by western blots using anti-myc
antibody, although additional slow migrating bands as
well as an expected band for C3 protein were observed
(Figure 5C and data not shown). We also conﬁrmed
nuclear localization of the proteins by immunoﬂuores-
cence (data not shown). Previously we reported that the
C-terminal region of zebraﬁsh Fox-1 protein, in addition
to the RNA-recognition motif (RRM), was required to
induce exon 9 skipping of the hF1g gene (15). The amino-
terminally truncated and carboxyl-terminally truncated
mFox-1 proteins were co-expressed with the hF1gL mini-
gene. As a result, the intact Fox-1, N (117–396 aa), C3
(1–338 aa) and C4 (1–355 aa) induce exon 9 skipping of
the hF1g, while C1 (1–307 aa) and C2 (1–326 aa) did
not (Figure 5B, lanes 1–5 and data not shown). These
results indicate that the amino-terminal 117 amino acids
are dispensable, whereas the carboxyl-terminal amino
acids are involved in the repression of intron 9 splicing by
Fox-1 protein. In particular, the 326–338 aa portion of the
C-terminal region of Fox-1 protein may play a critical role
for the negative regulation.
DISCUSSION
Fox-1 represses intron 9splicing toinduce exon 9skipping
Fox-1 protein can act as a negative regulator of alternative
splicing via binding to (U)GCAUG repressor elements in
upstream introns of the cassette exons. In contrast, all of
the (U)GCAUG enhancer elements are found down-
stream of the regulated exons. Thus, Fox-1 proteins can
fuction either positively or negatively, depending on where
they bind relative to the aﬀected exon. In this study, we
examined the mechanism of exon skipping by Fox-1 using
the hF1g gene as a model. We found that Fox-1 protein
induces exon 9 skipping by repressing the splicing of
intron 9 via binding to the GCAUG repressor elements in
intron 8 (Figure 2A and C). Our data suggest that, for
exon 9 inclusion, intron 9 excision is usually followed by
intron 8 splicing of hF1g pre-mRNA. Interestingly, Fox-1
does not aﬀect splicing of the intron 8 containing the
GCAUG repressor element (Figure 2B), suggesting that
Fox-1 dose not interfere with the spliceosome assembly
on intron 8.
It is very interesting that Fox-1 binds to an intron
(intron 8 in the case of F1g) to repress splicing of another
intron (intron 9 of F1g). Known negative regulators of
alternative splicing such as hnRNP A1 and PTB
(hnRNP I) inhibit splicing of the intron that they bind
or mask the regulated exon via binding to both of the
ﬂanking introns (25–27). Tissue-speciﬁc splicing regulators
Mock
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DC3
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hF1gL
A
RRM Fox-1
1 117 196 396
DN (117-396)
DC1 (1-307)
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DC3 (1-338)
DC4 (1-355)
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C
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1
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(kDa)
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Figure 5. Identiﬁcation of the functional region of Fox-1 protein
required for alternative exon skipping. (A) Diagrams of full-length and
truncated mutants of mFox-1 proteins. (B) Transfection analyses of the
hF1g L mini-gene. The hF1g L mini-gene (lanes 1–5) were co-expressed
in CV-1 cells along with pCS2+MT vector (lane 1), mFox-1 (lane 2),
N (lane 3), C2 (lane 4), and C3 (lane 5). The splicing products
were analyzed by RT-PCR. The positions of spliced products are
indicated on the right. (C) Western blotting of cell extracts to detect
Fox-1 truncated mutants of Fox-1 proteins: Each of the truncated
mutants was expressed from the pCS2+MT vector using the anti-Myc
antibody. In lane 5, additional slow migrating bands as well as an
expected band for C3 protein were observed.
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of the intron containing their binding sites (13,14,28,29).
In the cases such as FGFR2 exon IIIb, it was reported that
intronic silencers function across the exon (30), although
the molecular mechanism underlying the regulation
remains unclear. Thus, the cross-exon repression by
Fox-1 may represent a novel mode of splicing regulation
by tissue-speciﬁc splicing regulators. It is possible that
other determinants, including RNA secondly structure
(31), may be involved in this type of splicing regulation.
Interestingly, Zhou et al. (17) recently reported that Fox-1
and Fox-2 proteins bind to two GCAUG elements in
exon 4 and its upstream intron of calcitonin/CGRP pre-
mRNA, inhibiting splicing of this upstream intron. Thus,
it is possible that Fox-1 induces exon skipping by multiple
mechanisms.
Fox-1represses Ecomplex formationon intron 9ofF1c
pre-mRNA
Our in vitro splicing analyses showed that Fox-1 protein
blocks the pre-spliceosomal E complex formation on
intron 9 of hF1g pre-mRNA (Figures 3 and 4). The E
complex contains the U1 snRNP and the spliceosomal
proteins SF1 and the U2AF heterodimer. In addition, U2
snRNP is loosely associated with the complex. Kent et al.
(5) showed that the ATP-independent E0 complex is
formed prior to E complex formation, with U1 snRNP
and SF1 protein. Since our present experiments could not
distinguish the E0 complex from the E complex, we think it
possible that Fox-1 blocks the E0 complex formation.
Recently, Ule et al. (29) showed Nova1 inhibits splicing
of an RNA substrate containing Nova1-binding sites
(YCAY clusters) by blocking U1 snRNP binding, result-
ing in the induction of exon skipping. Although Fox-1
does not inhibit the splicing of intron 8, which contains
Fox-1-binding sites, it is possible that Fox-1 in some way
acts across exon 9 of the hF1g gene to prevent U1 snRNP
assembly at the 50 splice site in intron 9.
It has been shown that components of U1 snRNP are
direct targets of several splicing regulator. For example,
TIA-1 protein interacts with U1C protein, one of the
U1 snRNP components, and recruits U1 snRNP to the
50 splice site (32). The Drosophila PSI protein represses
splicing by interaction with the U1-70K protein (33).
Notably, it was reported that Fox-1 and Fox-2 interact
with U1C protein in a yeast two-hybrid screening (34).
When Fox-1 protein binds to the (U)GCAUG repressor
element upstream of the alternative exon, Fox-1 may
repress the splicing of the downstream intron by interact-
ing with U1C protein.
Alternatively, Fox-1 may interfere with the interactions
between U1 snRNP and U2AF. Izquierdo et al. (35)
reported that PTB binding to exon inhibits the exon
deﬁnition. More recently, Sharma et al. (36) indicates that
PTB binds to the ﬂanking introns of N1 exon, preventing
the association of U2AF with U1 snRNP that binds to the
50 splice site of the downstream intron. PTB protein
prevents the assembly of U2AF into the E complex,
probably without aﬀecting the binding of U1 snRNP
to the 50 splice site. Although our immunoprecipitation
experiments showed that Fox-1 does not interact with
U2AF heterodimer (our unpublished data), it is possible
that Fox-1 interacts directly or indirectly with U1 snRNP
components to prevent the association of U2AF with U1
snRNP. Thus, it will be interesting to study whether Fox-1
blocks association of U1 snRNP and U2AF to intron 9 or
the interaction between U1 snRNP and U2AF.
In this study, we identiﬁed that the carboxyl-terminal
region of mouse Fox-1 protein is required for inducing
exon skipping. In particular, the 326–338 aa C-terminal
region of the protein is essential for induction of exon
skipping. Our previous study showed that truncation of
the C-terminal 122 residues of zebraﬁsh Fox-1 protein
disrupts induction of exon skipping (15). Furthermore,
Baraniak et al. (20) showed that the C-terminal 84 amino
acids of the Fox-2 protein are required for the proper
regulation of FGFR2 exon choice, while the N-terminal
region of its protein is dispensable. These results suggest
that Fox proteins interact with some key proteins through
the C terminal region, functioning in both positive and
negative regulations. Several groups have reported on
proteins that interact with Fox protein. Human A2BP/
Fox was identiﬁed originally as an interacting protein
of ataxin-2 protein in yeast two-hybrid screening. The
C-terminal region of human A2BP1 is required for strong
interaction with ataxin-2 (37). The Fyn tyrosine kinase
and estrogen receptor-a interact with Fox-1 and Fox-2
(38,39). It remains to be elucidated whether these proteins
are involved in the splicing regulation. Moreover, further
identiﬁcation of interaction partners, including general
splicing factors, will be informative to clarify the
mechanisms of tissue-speciﬁc splicing regulation by Fox
proteins.
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